Latest Enzyme Stories
SAN DIEGO, Dec. 10, 2012 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today announced the signing of a $22.5 million secured debt financing with the Athyrium Opportunities Fund ("Athyrium"). (Logo: http://photos.prnewswire.com/prnh/20120924/MM79973LOGO) Net proceeds after estimated expenses will be approximately $21.3 million, providing Verenium with...
ALBANY, New York, November 12, 2012 /PRNewswire/ -- According to a new market report published by Transparency Market Research (http://www.transparencymarketresearch.com) "Biofuel Enzymes Market- Global Industry Size, Market Share, Trends, Analysis and Forecast, 2012 - 2018 [http://www.transparencymarketresearch.com/biofuel-enzymes-market.html ]," the global biofuel enzymes demand was worth USD 1,021.9 million in 2011 and is expected to reach USD 1,653.1 million in 2018,...
SAN DIEGO, Nov. 8, 2012 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today reported operating highlights and financial results for the third quarter and nine months ended September 30, 2012. (Logo: http://photos.prnewswire.com/prnh/20120924/MM79973LOGO) "During the third quarter we made some important steps forward with our manufacturing investment...
IPSWICH, Mass., Nov. 8, 2012 /PRNewswire/ -- New England Biolabs (NEB) has recently received a $640,000 Phase II Small Business Innovation Research (SBIR) grant to expand its research and product development of novel enzymatic tools for epigenetic analysis. This latest grant adds to the more than $1.1 million of SBIR funds awarded for this research since 2009. (Logo: http://photos.prnewswire.com/prnh/20090921/NE79207LOGO-b ) Since its establishment in 1974, NEB has been dedicated...
SAN DIEGO, Nov. 1, 2012 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today announced that it will release 2012 third quarter financial results on Thursday, November 8, 2012 after market close. In conjunction with the release, the Company will host a conference call with live webcast on Thursday, November 8, 2012 at 5:00 p.m. ET. (Logo:...
BOCA RATON, Fla., Oct. 30, 2012 /PRNewswire/ -- Brenda Watson of Renew Life, a company dedicated to all-natural digestive care solutions, appears on The SUZANNE Show this week to discuss digestive enzymes. Her appearance, which is the last in a four-part series detailing the nutrients needed to achieve optimal digestive health and overall wellness, airs Wednesday, October 31(st), at 7:00 am (ET/PT) on Lifetime Television. Digestive enzymes break down the food that we eat and convert...
Using a computational model they designed to incorporate detailed information about plants’ interconnected metabolic processes, scientists at the U.S. Department of Energy’s Brookhaven National Laboratory have identified key pathways that appear to “favor” the production of either oils or proteins. The research, now published online in Plant Physiology, may point the way to new strategies to tip the balance and increase plant oil production. The study focused on the metabolism of...
SAN DIEGO, Oct. 8, 2012 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today announced that it has entered into an agreement with Comerica Bank for a two-year, $10 million revolving credit facility. (Logo: http://photos.prnewswire.com/prnh/20120924/MM79973LOGO) This credit facility will allow Verenium to borrow up to $8.4 million against eligible...
SAN DIEGO, Oct. 2, 2012 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today announced that it will host a live webcast of its Capital Markets Day for investors and analysts on Tuesday, October 9, 2012 in New York City. The webcasted presentations and Q&A will begin at 8:00 a.m. and are expected to conclude at 11:00 a.m. ET. (Logo:...
Alan McStravick for redOrbit.com - Your Universe Online In 1935, a brilliant scientist became the father of a new field of chemistry. Polymers, which occur both naturally in organic compounds like proteins and starches as well as synthetically as plastics, were the focus of Wallace Carothers’ research, an Iowa-born accounting student at Tarkio College who later changed his field of study to science. While still an undergraduate he was appointed head of the chemistry department. While...
